Latest news
Loading news…
CymaBay Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Hayward, California, United States Founded 1991 51-100 employees For Profit
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
CymaBay Therapeutics was acquired by Gilead Sciences in 2024 for $4B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
63
Ticker
CBAY
NASDAQ
Patents
16
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- CBAY
- Exchange
- NASDAQ
- IPO date
- Jul 18, 2014
- Raised at IPO
- $22M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Active products
- 12
- Patents granted
- 16
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 1991
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 96
- HQ
- Hayward, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Exit date
- Jul 18, 2014
- Closed
- Jan 1, 2024
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0.7
- Trend (90d)
- 0
- Last leadership hire
- Nov 1, 2022
Key People at CymaBay Therapeutics
Chief Scientific Officer and President of Research and Development
Chief Regulatory and Compliance Officer
Vice President and Franchise Lead
Head of Medical Affairs and Vice President
63
professional contacts at CymaBay Therapeutics
Contact execs at CymaBay Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CymaBay Therapeutics
Loading news…
FAQs about CymaBay Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.